XNCR – xencor, inc. (US:NASDAQ)

News

Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy [Seeking Alpha]
Xencor: Fortress Balance Sheet Bodes Well For XmAb819 And XmAb942 [Seeking Alpha]
Calculating The Fair Value Of Xencor, Inc. (NASDAQ:XNCR) [Yahoo! Finance]
Xencor (NASDAQ:XNCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com